Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research.
- Climbing The Blockchain Ladder To Optimize Clinical Supply Forecasting
- Counting The Steps To Decentralized Personalized Therapy Manufacturing
- 3 Strategies For mAb Manufacturing: How Do You Choose?
- Trends In FDA FY 2024 Inspection-Based Warning Letters
- Challenges In Manufacturing TIL For Clinical Trials
- 4 Key Steps To Build Supply Chains For Later-Stage Clinical Trials In LMICs
- The Rise Of AI-Powered Drones In Clinical Logistics And Supply Chains
- Deciphering FDA's 7-Step Framework For AI-Driven Decision-Making
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Planning Your Packaging For A Seamless Transition From Clinic To Launch
Explore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
Cryobag Container Development For Cell & Gene Therapies
ISR Reports addresses the logistical challenges faced by developers of cell and gene therapies regarding cold chain and cryopreservation.
-
Outsourcing Your Highly Potent Oncology Drug Product
Precision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
-
Gain Confidence In Clinical Trial Outcomes
Delve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Building Robust Clinical Supply Chains To Support Global Trials
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
Top 5 Dos And Don'ts Of RTSM
Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
Transportation Solutions For Cell And Gene Therapy Supply Chains
Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
Overcoming Cell Therapy Supply Chain Challenges
For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.
CATALENT CORNER

Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.